文献速递生殖医学

GnRH拮抗剂对正常女性卵泡成熟的影响

The effect of a GnRH antagonist on follicle maturation in normal women.
PubMed 文献 · Reprod Biomed Online · 2019-03-11

研究纳入10名月经周期正常的女性,比较对照周期与加尼瑞克周期。加尼瑞克治疗期间LH在第3、4、7、9天较对照显著降低(P < 0.05),FSH和雌二醇保持稳定;第10天起对照周期可见卵泡成熟而加尼瑞克周期未见,10名女性中9名在对照周期排卵,8名在加尼瑞克周期排卵延迟至少1周,仅1名在治疗期间出现卵泡生长和排卵。作者认为加尼瑞克通过作用于卵巢干扰卵泡选择过程。

要点

  • 加尼瑞克0.25 mg/天皮下注射期间LH在第3、4、7、9天较对照显著降低(P < 0.05)。
  • 加尼瑞克周期第10天起未见卵泡成熟,对照周期可见。
  • 10名女性中9名对照周期排卵,8名加尼瑞克周期排卵延迟至少1周,仅1名治疗期间排卵。

核心结论

  • 本研究首次在正常女性中显示加尼瑞克治疗期间优势卵泡选择失败。
  • 由于两个周期促性腺激素谱相似,作者认为加尼瑞克通过作用于卵巢干扰卵泡选择过程。

研究设计与样本

  • 对10名月经周期正常的女性在两个月经周期(周期1为对照,周期2为加尼瑞克)进行研究。
  • 两个周期均从第2天起每日采血,并在周期第8天和第10天及之后每日行经阴道超声扫描。
  • 周期2中所有女性从第2天至周期1内源性LH峰起始日每日皮下注射0.25 mg加尼瑞克。

主要发现

  • 加尼瑞克治疗期间血清FSH和雌二醇浓度保持稳定,LH浓度在第3、4、7、9天较对照显著降低(P < 0.05)。
  • LH浓度在周期内无显著变异。
  • 从第10天起,周期2未见卵泡成熟,而周期1可见。
  • 周期1中10名女性有9名排卵;周期2中8名女性排卵延迟至少1周。
  • 仅1名女性在加尼瑞克治疗期间出现卵泡生长和排卵。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Ganirelix is a gonadotrophin-releasing hormone (GnRH) antagonist used for the prevention of premature LH surge during ovarian stimulation. What is the impact of ganirelix on follicle maturation in normal women? DESIGN: Ten normally cycling women were investigated during two menstrual cycles, i.e. cycle 1 (control) and cycle 2 (ganirelix). During both cycles, daily blood samples were taken from day 2, while transvaginal ultrasound scans were performed on cycle days 8 and 10 and daily thereafter. During cycle 2, all women were given 0.25 mg/day subcutaneous injections of the GnRH antagonist ganirelix from day 2 until the day of the endogenous LH surge onset in cycle 1. RESULTS: During treatment with ganirelix, serum FSH and oestradiol concentrations remained stable, while those of LH decreased significantly on days 3, 4, 7 and 9 (P < 0.05) compared with controls. Nevertheless, there was no significant within-cycle variation in LH concentrations. From day 10 onwards, no follicle maturation was observed in cycle 2, in contrast to cycle 1. Ovulation occurred in 9 of 10 women in cycle 1. In cycle 2, ovulation was delayed by at least 1 week in eight women. Follicle growth and ovulation occurred in only one woman while on ganirelix treatment. CONCLUSIONS: This study demonstrates for the first time that in normal women dominant follicle selection failed during treatment with ganirelix. As there was a similar gonadotrophin profile in the two cycles, it is suggested that ganirelix interferes with the process of follicle selection by acting in the ovary.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Pousias S, Messini CI, Anifandis G, et al. The effect of a GnRH antagonist on follicle maturation in normal women. Reprod Biomed Online. 2019. PMID: 31129014. doi:10.1016/j.rbmo.2019.03.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。